Latest Blogs

Subscribe to this column

Bruce E. Johnson, MD, FASCO

Bruce E. Johnson, MD, FASCO, is the 2017-2018 ASCO President. He is chief clinical research officer and institute physician at the Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School. He is the director of the Dana-Farber/Harvard Cancer Center (DF/HCC) Lung Cancer Program. He served as director of the Lowe Center for Thoracic Oncology from 1998 through 2013.
 
An ASCO member since 1985, Dr. Johnson has served in numerous volunteer and leadership roles, including the Board of Directors (2008-2011), Chair of the Audit, Cancer Education, and Cancer Communications Committees, and on the Journal of Clinical Oncology Editorial Board, among other positions. In 2008, he was awarded the Translational Research Professorship from the Conquer Cancer Foundation of ASCO; in 2012, he was elected as a Fellow of ASCO (FASCO).

Jul 11, 2017
The price of and access to oncology drugs remains both a national and international challenge to our patients, providers, and third-party payers.
Jun 13, 2017
Dr. McAneny's broad expertise and insight on today’s challenging health care environment will greatly benefit the practice of medicine and our patients.
Jun 12, 2017
Preparing for the future starts with gaining clarity about the present state of oncology care. Our goal is for practices in all settings across the U.S. to provide feedback in the 2017 ASCO Practice Census.